Christopher Daugherty, | |
5841 S Maryland Ave, Chicago, IL 60637-1443 | |
(888) 824-0200 | |
Not Available |
Full Name | Christopher Daugherty |
---|---|
Gender | Male |
Speciality | Hematology/oncology |
Experience | 35 Years |
Location | 5841 S Maryland Ave, Chicago, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063574523 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 036087565 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The University Of Chicago Medical Center | Chicago, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The University Of Chicago Medical Center | 7618880766 | 754 |
University Of Chicago | 7719899426 | 1137 |
News Archive
A new approach to optical imaging makes it possible to quickly and economically monitor multiple molecular interactions in a large area of living tissue - such as an organ or a small animal; technology that could have applications in medical diagnosis, guided surgery, or pre-clinical drug testing.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
Kaiser Health News provides a fresh take on health policy developments with "Look, Up In The Sky ..." by Nate Beeler.
Small intravenous devices (IVDs) commonly used in the hand or arm do not need to be moved routinely every 3 days. A randomized controlled trial comparing regular relocation with relocation on clinical indication, published in the open access journal BMC Medicine, found that rates of complications were the same for both regimens.
› Verified 3 days ago
Entity Name | University Of Chicago |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821048786 PECOS PAC ID: 7719899426 Enrollment ID: O20031103000094 |
News Archive
A new approach to optical imaging makes it possible to quickly and economically monitor multiple molecular interactions in a large area of living tissue - such as an organ or a small animal; technology that could have applications in medical diagnosis, guided surgery, or pre-clinical drug testing.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
Kaiser Health News provides a fresh take on health policy developments with "Look, Up In The Sky ..." by Nate Beeler.
Small intravenous devices (IVDs) commonly used in the hand or arm do not need to be moved routinely every 3 days. A randomized controlled trial comparing regular relocation with relocation on clinical indication, published in the open access journal BMC Medicine, found that rates of complications were the same for both regimens.
› Verified 3 days ago
Entity Name | The University Of Chicago Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033218128 PECOS PAC ID: 7618880766 Enrollment ID: O20031106000203 |
News Archive
A new approach to optical imaging makes it possible to quickly and economically monitor multiple molecular interactions in a large area of living tissue - such as an organ or a small animal; technology that could have applications in medical diagnosis, guided surgery, or pre-clinical drug testing.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
Kaiser Health News provides a fresh take on health policy developments with "Look, Up In The Sky ..." by Nate Beeler.
Small intravenous devices (IVDs) commonly used in the hand or arm do not need to be moved routinely every 3 days. A randomized controlled trial comparing regular relocation with relocation on clinical indication, published in the open access journal BMC Medicine, found that rates of complications were the same for both regimens.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Christopher Daugherty, 150 Harvester Dr, Suite 300, Burr Ridge, IL 60527-5919 Ph: () - | Christopher Daugherty, 5841 S Maryland Ave, Chicago, IL 60637-1443 Ph: (888) 824-0200 |
News Archive
A new approach to optical imaging makes it possible to quickly and economically monitor multiple molecular interactions in a large area of living tissue - such as an organ or a small animal; technology that could have applications in medical diagnosis, guided surgery, or pre-clinical drug testing.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
Kaiser Health News provides a fresh take on health policy developments with "Look, Up In The Sky ..." by Nate Beeler.
Small intravenous devices (IVDs) commonly used in the hand or arm do not need to be moved routinely every 3 days. A randomized controlled trial comparing regular relocation with relocation on clinical indication, published in the open access journal BMC Medicine, found that rates of complications were the same for both regimens.
› Verified 3 days ago
Dr. Sorin C Danciu, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |